ProfileGDS4718 / 224499_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 20% 21% 16% 18% 17% 16% 15% 17% 23% 16% 18% 70% 16% 11% 20% 39% 12% 16% 9% 12% 17% 15% 18% 22% 17% 13% 19% 28% 15% 21% 16% 16% 27% 14% 18% 12% 15% 25% 53% 13% 20% 13% 15% 18% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1716220
GSM549102patient 115, normal, homogenized [OPG study]4.2026421
GSM549104patient 119, normal, homogenized [OPG study]3.9789916
GSM549108patient 138, normal, homogenized [OPG study]4.0912418
GSM549119patient 077, normal, homogenized [OPG study]4.0369717
GSM549133patient 032, cancer, homogenized [OPG study]3.9372216
GSM549139patient 042, cancer, homogenized [OPG study]3.9357415
GSM549099patient 107, normal, homogenized [OPG study]4.0613217
GSM549109patient 139, normal, homogenized [OPG study]4.323
GSM549110patient 046, normal, homogenized [OPG study]4.0031216
GSM549114patient 063, normal, homogenized [OPG study]4.0242518
GSM549122patient 082, normal, homogenized [OPG study]6.8904170
GSM549134patient 033, cancer, homogenized [OPG study]3.9999316
GSM549136patient 036, cancer, homogenized [OPG study]3.7575111
GSM549140patient 044, cancer, homogenized [OPG study]4.0968420
GSM549111patient 047, normal, homogenized [OPG study]4.9269439
GSM549113patient 057, normal, homogenized [OPG study]3.827912
GSM549132patient 031, cancer, homogenized [OPG study]3.9712616
GSM549137patient 038, cancer, homogenized [OPG study]3.756849
GSM549142patient 047, cancer, homogenized [OPG study]3.9250812
GSM549100patient 110, normal, homogenized [OPG study]4.0287117
GSM549107patient 135, normal, homogenized [OPG study]3.9326515
GSM549115patient 068, normal, homogenized [OPG study]4.025918
GSM549116patient 072, normal, homogenized [OPG study]4.1835622
GSM549120patient 078, normal, homogenized [OPG study]4.0429817
GSM549131patient 030, cancer, homogenized [OPG study]3.8426813
GSM549118patient 074, normal, homogenized [OPG study]4.104719
GSM549129patient 027, cancer, homogenized [OPG study]4.4578328
GSM549123patient 088, normal, homogenized [OPG study]3.9771615
GSM549124patient 006, cancer, homogenized [OPG study]4.2300921
GSM549126patient 015, cancer, homogenized [OPG study]3.9737916
GSM549128patient 025, cancer, homogenized [OPG study]3.9580816
GSM549103patient 117, normal, homogenized [OPG study]4.4525227
GSM549117patient 073, normal, homogenized [OPG study]3.9222814
GSM549138patient 041, cancer, homogenized [OPG study]4.048818
GSM549141patient 045, cancer, homogenized [OPG study]3.8145112
GSM549130patient 028, cancer, homogenized [OPG study]3.9709615
GSM549101patient 111, normal, homogenized [OPG study]4.341125
GSM549105patient 128, normal, homogenized [OPG study]5.7134853
GSM549106patient 134, normal, homogenized [OPG study]3.8513913
GSM549112patient 048, normal, homogenized [OPG study]4.1473120
GSM549125patient 011, cancer, homogenized [OPG study]3.8806713
GSM549127patient 024, cancer, homogenized [OPG study]3.9435715
GSM549135patient 035, cancer, homogenized [OPG study]4.0143518